The Size of the ureteral Stents Market in the Asia Pacific is valued at USD xx Million in 2020 and is poised to reach USD xx Million by 2025, to grow at a CAGR of xx.x% during the forecast period 2020-2025.
Ureteral stent refers to a tube that is implanted in the ureter to treat blockage of urine flow from the kidney. The stent is inserted with the help of cystoscopy and the length of the stent ranges from 24 cm to 30 cm. The ends of the stent are coiled to keep them in place.
The significant drivers are increasing incidence of medical conditions that require ureteral stents, growing cases of kidney stones. Increasing geriatric population and an increase in government funding are also expected to drive the market over the forecast period. However, infections caused due to urinary stent and an increase in the frequency of urination are major restraints limiting this industry.
Asia Pacific Ureteral Stents Market has been segmented and sub-segmented into the following categories
On the basis of region, the Asia Pacific has significant growth owing to the increasing population and growing awareness.
Top Companies leading the Asia Pacific Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation and Medline Industries, Inc.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Patient's Sex
5.1.1 Introduction
5.1.2 Female
5.1.3 Male
5.1.4 Y-o-Y Growth Analysis, By Patient's Sex
5.1.5 Market Attractiveness Analysis, By Patient's Sex
5.1.6 Market Share Analysis, By Patient's Sex
5.2 Type
5.2.1 Introduction
5.2.2 Expandable Stent
5.2.3 Double pigtail stent (JJ Stent)
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Medical Situation
5.3.1 Introduction
5.3.2 Kidney Failure
5.3.3 Kidney Stones
5.3.3.1 Ureteroscopy
5.3.3.2 Ureteroenoscopy
5.3.4 Tumors
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By Medical Situation
5.3.7 Market Attractiveness Analysis, By Medical Situation
5.3.8 Market Share Analysis, By Medical Situation
5.4 End-User
5.4.1 Introduction
5.4.2 Hospital
5.4.3 Clinical
5.4.4 Y-o-Y Growth Analysis, By End User
5.4.5 Market Attractiveness Analysis, By End User
5.4.5 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Patient's Sex
6.1.3.3 By Type
6.1.3.4 By Medical Situation
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Patient's Sex
6.1.4.3 By Type
6.1.4.4 By Medical Situation
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Patient's Sex
6.1.5.3 By Type
6.1.5.4 By Medical Situation
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cook Medical Inc.
8.3 C. R. Bard, Inc.
8.4 Medline Industries, Inc.
8.5 Pnn Medical
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
